Tempus AI, Inc.NASDAQ: TEM

Tempus to Report Second Quarter 2026 Financial Results on July 30

· Issued by Tempus AI, Inc. via Business Wire

Summary by 6ix AI

Tempus AI, Inc., a technology company that applies artificial intelligence to precision medicine, will report financial results for the second quarter ended June 30, 2026, on Thursday, July 30, 2026, and host a conference call and live audio webcast at 4:30 p.m. ET.

Key details

  • The call will be led by Founder and CEO Eric Lefkofsky and Chief Financial Officer Jim Rogers, and will cover the results and a business update.
  • The webcast will be available in the Events section of the Tempus Investor Relations website, and a recording will be posted there after the call.

6ix AI wrote this summary from the release below and checked it against the release.

CHICAGO, July 09, 2026--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it will report financial results for the second quarter ended June 30, 2026, on Thursday, July 30, 2026.

The company will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the results and provide a business update. The call will be led by Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers.

The live audio webcast will be accessible through the "Events" section of the Tempus Investor Relations website or by clicking here. Alternatively, the call can be accessed via the following:

Conference ID: 9053038
United States - New York: (646) 307-1963
USA & Canada - Toll-Free: (800) 715-9871

For those unable to listen to the live broadcast, a recording will be available on the website following the call.

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit www.tempus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260709536726/en/

Contacts

Tempus IR
Elizabeth Krutoholow
investorrelations@tempus.com

Tempus Communications
hanah.heintzelman@tempus.com

View original source (Business Wire)Tempus AI, Inc. on 6ix

Story so far

Earlier from Tempus AI

Later from Tempus AI

All Tempus AI news releases